Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Kyowa Hakko Kirin Co Ltd    4151   JP3256000005

SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on KYOWA HAKKO KIRIN CO LTD
01/10 KYOWA HAKKO KIRIN : to develop and commercialize Syndax entinostat in Japan and ..
01/08 KYOWA HAKKO KIRIN : to develop and commercialize Syndax's entinostat in Japan an..
2014 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for final dividend
2014 KYOWA HAKKO KIRIN : Approval for Additional Indication for Chemotherapy-Native C..
2014 KYOWA HAKKO KIRIN : Approval for Additional Indication of NESP® for Anemia with ..
2014 Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
2014 KYOWA HAKKO KIRIN : New Influenza A Virus Subtype H1N1 Study Findings Recently W..
2014 Ono Pharma, Bristol-Myers & Kyowa Hakko Kirin enter pact to condutct phase 1 ..
2014 Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
2014 Kyowa Hakko Kirin -Launch of Sustained-Duration G-CSF Product G-Lasta in Japa..
2014 KYOWA HAKKO KIRIN : Launch of Sustained-Duration G-CSF Product G-Lasta® in Japan
2014 KYOWA HAKKO KIRIN : Patent Application Titled "Oligonucleotide" Published Online
2014 KYOWA HAKKO KIRIN : Completion of Construction for Drug Product Manufacturing Fa..
2014 KYOWA HAKKO KIRIN : Announces Completion of Construction for Drug Product Manufa..
2014 KYOWA HAKKO KIRIN : Completion of Construction for Drug Product Manufacturing Fa..
2014 Pfizer and Kyowa Hakko Kirin to Partner on Immuno-Oncology Combination Study
2014 Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination St..
2014 Pfizer and Kyowa Hakko Kirin to Partner on Immuno-Oncology Combination Study
2014 Approval for Sustained-Duration G-CSF Product G-Lasta in Japan
2014 KYOWA HAKKO KIRIN : Approval for Sustained-Duration G-CSF Product G-Lasta® in Ja..
2014 KYOWA HAKKO KIRIN : Announcement of Results from Long-Term Phase 1/2 Study of KR..
2014 KYOWA HAKKO KIRIN : Launch of Redesigned Kyowa Hakko Kirin Pharma Website
2014 Kyowa Hakko Kirin Announces Commencement of Phase 2b Clinical Study of KHK758..
2014 KYOWA HAKKO KIRIN : Announces Commencement of Phase 2b Clinical Study of KHK7580..
2014 KYOWA HAKKO KIRIN : Submits Application for Approval in Japan for KW-3357
2014DJU.S. Stocks Fall Sharply
2014 AstraZeneca buys Almirall lung drugs for up to $2.1 billion
2014 KYOWA HAKKO KIRIN : KIRIN -Announcement of Start of Phase 1 Joint Japanese-Korea..
2014 KYOWA HAKKO KIRIN : Announcement of Start of Phase 1 Joint Japanese-Korean Study..
2014 KYOWA HAKKO KIRIN : Announces Initiation of a Phase 2 Study of KRN23 for Pediatr..
2014 KYOWA KIRIN -Topical Combination Drug Dovobet Ointment Approved to Treat Psor..
2014 KYOWA HAKKO KIRIN : Topical Combination Drug Dovobet® Ointment Approved to Treat..
2014 KYOWA HAKKO KIRIN : Future Development Direction for Bardoxolone Methyl (RTA 402..
2014 KYOWA HAKKO KIRIN : Reapplication Seeking Approval for Additional Indication for..
2014 KYOWA HAKKO KIRIN : Reapplication Seeking Approval for Additional Indication for..
2014 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for interim dividend
2014 KYOWA HAKKO KIRIN : Announcement of Results from a Multiple Dose Phase 1/2 Study..
2014 KYOWA HAKKO KIRIN : Announcement of Results from a Multiple Dose Phase 1/2 Study..
2014 KYOWA KIRIN -Hisamitsu Pharmaceutical is received Approval for Additional Ind..
2014 KYOWA HAKKO KIRIN : Hisamitsu Pharmaceutical is received Approval for Additional..
2014 KYOWA HAKKO KIRIN : initiates a Phase I Trial of KHK6640 for Alzheimer's Disease..
2014 KYOWA HAKKO KIRIN : Drugmaker workers inappropriately involved in clinical study
2014 KYOWA HAKKO KIRIN : KIRIR -Launch of a New Formulation of Topina, an Antiepilept..
2014 KYOWA HAKKO KIRIN : Launch of a New Formulation of Topina®, an Antiepileptic Age..
2014 KYOWA HAKKO KIRIN : KIRIN -Termination of Mogamulizumab Licensing Agreement with..
2014 KYOWA HAKKO KIRIN : Termination of Mogamulizumab Licensing Agreement with Amgen
2014 KYOWA HAKKO KIRIN : initiated a Pivotal Phase 3 Trial of Benralizumab (KHK4563) ..
2014 KYOWA HAKKO KIRIN : KIRIN -Completion of Construction for the biopharmaceutical ..
2014 KYOWA HAKKO KIRIN : Completion of Construction for the biopharmaceutical API man..
2014 KYOWA HAKKO KIRIN : KIRIN -Application Seeking Approval for Additional Indicatio..
2014 KYOWA HAKKO KIRIN : Application Seeking Approval for Additional Indication of NE..
2014 KYOWA HAKKO KIRIN : Matters concerning controlling shareholders(23KB)
2014 KYOWA HAKKO KIRIN : Submits Application for Approval of REGPARA Tablets 12.5mg i..
2014 KYOWA HAKKO KIRIN : Submits Application for Approval of REGPARA® Tablets 12.5mg ..
2014 KYOWA HAKKO KIRIN : Notice regarding allotment of stock acquisition rights(stock..
2014 KYOWA HAKKO KIRIN : Lonza and BioWa Sign POTELLIGENT® CHOK1SV Cell Line Technolo..
2014 KYOWA HAKKO KIRIN : KIRIN -Approval for Additional Indication for PTCL and CTCL ..
2014 KYOWA HAKKO KIRIN : Approval for Additional Indication for PTCL and CTCL of Moga..
2014 Orexo Announces Full year report January-December 2013
2014 KYOWA HAKKO KIRIN CO LTD : Correction of one section of the Consolidated Financi..
2014 KYOWA HAKKO KIRIN CO LTD : Construction to Begin on New IK8 Research Building at..
2014 KYOWA HAKKO KIRIN CO LTD : Researchers Submit Patent Application, "Method of Pur..
2014 KYOWA HAKKO KIRIN CO LTD : Correction of one section of the Consolidated Financi..
2014 KYOWA HAKKO KIRIN CO LTD : KYOWA KIRIN -Approval for Additional Indication of RE..
2014 KYOWA HAKKO KIRIN CO LTD : Approval for Additional Indication of REGPARA® Tablet..
2014 ArQule Begins Phase 3 Clinical Trial with Tivantinib in Hepatocellular Carcin..
2014 KYOWA HAKKO KIRIN CO LTD : KYOWA KIRIN - Change to Supplemental Application Seek..
2014 KYOWA HAKKO KIRIN CO LTD : Change to Supplemental Application Seeking Approval o..
2014 ArQule Begins Phase 3 Clinical Trial with Tivantinib in Hepatocellular Carcin..
2014 KYOWA HAKKO KIRIN CO LTD : Kyowa Hakko Kirin Announces Commencement of Phase 3 C..
2014 KYOWA HAKKO KIRIN CO LTD : IPO Report: Dicerna Pharmaceuticals (DRNA)
2014 KYOWA HAKKO KIRIN CO LTD : La Jolla Institute for Allergy and Immunology, Kyowa ..
2014 KYOWA HAKKO KIRIN CO LTD : Launch of Long-Acting Erythropoiesis-Stimulating Agen..
2014 KYOWA HAKKO KIRIN CO LTD : Approval of Fine Granules of Topina®, an Antiepilepti..
2014 KYOWA HAKKO KIRIN CO LTD : Addition of Japanese Sites for Pivotal Phase 3 Trial ..
1  2Next
Advertisement
Chart
Duration : Period :
Kyowa Hakko Kirin Co Ltd Technical Analysis Chart | 4151 | JP3256000005 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF